In Bong Ha

In Bong Ha

Auto-generated profile, based on publicly available information

In Bong Ha

Department of Radiation Oncology, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HCHoon Sik Choi
Hoon Sik Choi
KKKi Mun Kang
Ki Mun Kang
BJBae Kwon Jeong
Bae Kwon Jeong
JSJin Ho Song
Jin Ho Song
YLYun Hee Lee
Yun Hee Lee
HJHojin Jeong
Hojin Jeong
Choi HS, et al. J Korean Med Sci. 2018 Mar;33(14):e107. https://doi.org/10.3346/jkms.2018.33.e107

18 December 2017 in Computational and Mathematical Methods in Medicine
Verified
Journal Article
Open access
PDF file
HCHoon Sik Choi
Hoon Sik Choi
GJGuang Sub Jo
Guang Sub Jo
JCJong Pyo Chae
Jong Pyo Chae
SLSang Bong Lee
Sang Bong Lee
CKChul Hang Kim
Chul Hang Kim
JSJin Ho Song
Jin Ho Song
We evaluated the changes in the dose distribution of radiation during volumetric arc radiotherapy (VMAT), to determine the right time for adaptive replanning in prostate cancer patients with progressive weight (WT) changes. Five prostate cancer patients treated with VMAT were selected for dosimetric analysis. On the original computed tomography images, nine artificial body contours were created to reflect progressive WT changes. Combined with three different photon energies (6, 10, and 15-MV), 27 comparable virtual VMAT plans were created per patient. The dosimetric analysis included evaluation of target coverage (D95%,Dmax), conformity index, homogeneity index, and organs at risk doses. The dose differences among the plans were determined using the gamma index analysis and were compared with the dosimetric analysis. Mean D95% became lower than 98% when body contour expanded by 2.0 cm or more and Dmax became higher than 107% when body contour contracted by 1.5 cm or more in 10-MV plans. This cut-off values correlated well with gamma index analysis results. Adaptive replanning should, therefore, be considered if the depth of body contour becomes 1.5 cm smaller (WT loss) or 2.0 cm larger (WT gain) in patients treated by VMAT with 10-MV photons.

1 January 2015 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
BJBae Kwon Jeong
Bae Kwon Jeong
HJHojin Jeong
Hojin Jeong
IHIn Bong Ha
In Bong Ha
HCHoon Sik Choi
Hoon Sik Choi
SKSung Chul Kam
Sung Chul Kam
KKKi Mun Kang
Ki Mun Kang
Jeong BK, et al. J Korean Med Sci. 2015 Jun;30(6):710-715. http://dx.doi.org/10.3346/jkms.2015.30.6.710

1 January 2018 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
IHIn Bong Ha
In Bong Ha
BJBae Kwon Jeong
Bae Kwon Jeong
KKKi Mun Kang
Ki Mun Kang
HJHojin Jeong
Hojin Jeong
YLYun Hee Lee
Yun Hee Lee
JSJin Ho Song
Jin Ho Song
Ha IB, et al. J Korean Med Sci. 2018 Apr;33(18):e135. https://doi.org/10.3346/jkms.2018.33.e135

1 February 2018 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
BJBae Kwon Jeong
Bae Kwon Jeong
HCHoon Sik Choi
Hoon Sik Choi
KKKi Mun Kang
Ki Mun Kang
HJHojin Jeong
Hojin Jeong
YLYun Hee Lee
Yun Hee Lee
JSJin Ho Song
Jin Ho Song
442 Background: Portal vein tumor thrombosis (PVTT) is commonly accompanied by hepatocellular carcinoma (HCC) patients, and in these cases the treatment options became limited and treatment outcome was poor. Stereotactic body radiotherapy (SBRT) is one of the possible treatment options, which can deliver higher doses with highly conformal target have conducted for treatment of PVTT. However, only few studies about the SBRT have reported, even treatment schedules were not consistent. In this study, we report our institutional experience of treating PVTT in HCC patients using SBRT. Methods: 24 HCC patients with PVTT were treated with SBRT at our institution. All patients had unresectable HCC with PVTT, baseline liver function of Child-Pugh class A or B. SBRT was performed by Cyberknife based on 4D-simulation and 4D-planning. The prescription dose was 45 Gy in 3 fractions in 17 (70.8%) patients, and was modified to 39 to 42 Gy in 3 to 4 fractions in 7 (29.2%) patients whose target was large or adjacent to the bowel. After SBRT, transarterial chemoembolization (TACE) was performed in 16 (66.7%) patients within 3 months. Results: There were 2 (8.3%) patients of PVTT showed complete response, and 11 (45.8%) patients showed partial response. Stable disease was found in 7 (29.2%) patients, and progression in 4 (16.7%) patients. The response rate was lower in patients with tumor thrombus at main portal vein than those at branch of portal vein (main, 30% vs. branch, 71.4%, p = 0.052). The 1- and 2-year overall survival (OS) was 67.5%, 48.2%, respectively, with median survival of 20.8 months. The combination SBRT followed by TACE, and presence of grade 3 hepatic toxicities impacted on survival. The 1-year OS was 71.4% in patients whom TACE was combined after SBRT, which was higher than that of 14.6% who were treated with SBRT alone (p < 0.001). The 1-year OS was 81.1% in patients who did not occur grade 3 hepatic toxicity, while 0% in patients who had grade 3 hepatic toxicity (p = 0.002). Conclusions: SBRT is a relatively effective treatment option for HCC patients of PVTT. Especially combined with TACE. Finding an optimal dose schedule which can reduce hepatic toxicity, while keeping the response seems important to increase the survival.

20 October 2022 in Computational and Mathematical Methods in Medicine
Verified
Journal Article
Open access
PDF file
HCHoon Sik Choi
Hoon Sik Choi
KKKi Mun Kang
Ki Mun Kang
IHIn Bong Ha
In Bong Ha
BJBae Kwon Jeong
Bae Kwon Jeong
JSJin Ho Song
Jin Ho Song
HJHojin Jeong
Hojin Jeong
This study quantitatively analyzed the gain of the six-dimensional (6D) cone-beam CT (CBCT) correction method compared with the conventional set-up method in 60 patients who underwent radiation treatment of head and neck and brain tumors. The correction gain of CBCT was calculated for the translational and rotational motion components separately and in combination to evaluate the individual and overall effects of these motion components. Using a statistical simulation mimicking the actual set-up correction process, the effective gain of periodic CBCT correction during the entire treatment fraction was analyzed by target size and CBCT correction period under two different correction scenarios: translation alone and full 6D corrections. From the analyses performed in this study, the gain of CBCT correction was quantitatively determined for each situation, and the appropriate CBCT correction strategy was suggested based on treatment purpose and target size.